Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0162873 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE
Described herein are tricyclic compounds with phosphoinositide-3 kinase (PI3K) modulation activity or function having the Formula I structure: ##STR00001## or...
2018/0162872 Thienopyrimidine Compounds
Compounds of formula (I) are A.sub.2B receptor antagonists: ##STR00001## Wherein R.sub.1 is optionally substituted aryl or an optionally substituted 5- or...
2018/0162871 FLUORESCENT PROBE FOR DETECTING CALPAIN ACTIVITY
[Problem] To provide a fluorescent probe that detects calpain activity in cells at high sensitivity. [Solution] A compound represented by the following general...
2018/0162870 Process for the Preparation of Darunavir
The present invention provides a cost effective and industrially feasible process for preparation of Darunavir (I). Also described is the novel salt of...
2018/0162869 DRUG DELIVERY AND IMAGING CHEMICAL CONJUGATE, FORMULATIONS AND METHODS OF USE THEREOF
The present invention relates to compounds, and methods of use thereof, capable of entering macrophages. The invention further relates to compounds capable of...
2018/0162868 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically...
2018/0162867 EIS INHIBITORS
Compounds and compositions are disclosed, which are useful as inhibitors of acetyltransferase Eis, a mediator of kanamycin resistance in Mycobacterium...
2018/0162866 ACETATE SALT OF BUPRENORPHINE AND METHODS FOR PREPARING BUPRENORPHINE
The present disclosure provides acetate salts of buprenorphine, and its anhydrates, solvates, hydrates, and crystalline forms thereof, where the acetate salts...
2018/0162865 PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2- ...
The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-- ...
2018/0162864 PYRROLOPYRIMIDINE COMPOUND OR SALT THEREOF AND COMPOSITIONS CONTAINING THE PYRROLOPYRIMIDINE COMPOUND OR SALT...
A pyrrolopyrimidine compound or a salt thereof and compositions, NAE inhibitors and anti-tumor agents containing the pyrrolopyrimidine compound or a salt...
2018/0162863 TRICYCLIC COMPOUNDS HAVING CYTOSTATIC AND/OR CYTOTOXIC ACTIVITY AND METHODS OF USE THEREOF
The present invention provides tricyclic compounds having cytostatic and cytotoxic activity in a single molecule having receptor tyrosine kinase(s),...
2018/0162862 INHIBITORS OF BACTERIAL GLYCOSYL TRANSFERASES
Described herein are compounds of Formula (I'), Formula (IA), Formulae (I)-(VII), pharmaceutically acceptable salts, solvates, hydrates, polymorphs,...
2018/0162861 TYROSINE KINASE INHIBITORS
The present disclosure provides compounds that are tyrosine kinase inhibitors, in particular Bruton tyrosine kinase ("BTK") inhibitors, and are therefore...
2018/0162860 XANTHINE DERIVATIVE
The present invention relates to a Xanthine derivative as shown in formula (I), ##STR00001## wherein, R is selected from: ##STR00002## R.sup.1 is selected...
2018/0162859 TETRACYCLIC AUTOTAXIN INHIBITORS
Described herein are compounds that are autotaxin inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such...
2018/0162858 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
The invention provides a compound of Formula (I) ##STR00001## or a pharmaceutically acceptable salt of the compound, wherein R.sup.1, R.sup.2, R.sup.3, Z,...
2018/0162857 HISTONE DEMETHYLASE INHIBITORS
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted ...
2018/0162856 2-(PYRAZOLOPYRIDIN-3-YL)PYRIMIDINE DERIVATIVES AS JAK INHIBITORS
New 2-(pyrazolopyridin-3-yl)pyrimidine derivatives are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them, and...
2018/0162855 PDD AND BPD COMPOUNDS
The invention relates to pyrridinobenzodiazepines (PDDs) comprising three fused 6-7-6-membered rings and to benzopyrridodiazecines (BPDs) comprising three...
2018/0162854 Inhibitors of Leukotriene A4 Hydrolase
The present invention is directed to compounds encompassed by the Formula (I), pharmaceutical compositions thereof, methods for inhibiting LTA-4 hydrolase, and...
2018/0162853 CYCLOPROPANAMINE COMPOUND AND USE THEREOF
The present invention provides a compound having a lysine-specific demethylase-1 inhibitory action, and useful as a medicament such as a prophylactic or...
2018/0162852 NOVEL COMPOUNDS
The present invention relates to novel compounds and methods for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention...
2018/0162851 COMPOUNDS FOR THE MODULATION OF MYC ACTIVITY
The present invention provides novel compounds of Formula (I) and Formula (II) and pharmaceutically acceptable salts, solvates, hydrates, tautomers,...
2018/0162850 2,3-DIHYDRO-4H-1,3-BENZOXAZIN-4-ONE DERIVATIVES AS MODULATORS OF CHOLINERGIC MUSCARINIC M1 RECEPTOR
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as a...
2018/0162849 ANHYDROUS CRYSTALLINE FREE BASE FORM OF ...
A crystalline form of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzo- xazole is provided which is useful in the treatment of...
2018/0162848 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in...
2018/0162847 PRMT5 INHIBITORS CONTAINING A DIHYDRO- OR TETRAHYDROISOQUINOLINE AND USES THEREOF
Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present...
2018/0162846 SUBSTITUTED ANILINES AS CCR(4) ANTAGONISTS
Aniline compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft...
2018/0162845 ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
This invention relates to novel compounds according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions...
2018/0162844 CYCLOPROPANE DERIVATIVE AND DRUG CONTAINING SAME
Compounds represented by formula (I): ##STR00001## wherein each symbol is as defined herein exhibit superior TRPA1 antagonist activity and are useful for the...
2018/0162843 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
The present invention relates to compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic ...
2018/0162842 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette ("ABC") transporters...
2018/0162841 SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing,...
2018/0162840 3-(BENZOIMIDAZOL-2-YL)-INDAZOLE INHIBITORS OF THE WNT SIGNALING PATHWAY AND THERAPEUTIC USES THEREOF
Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an indazole...
2018/0162839 Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of...
Compounds of Formula (I): ##STR00001## pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the...
2018/0162838 Chemical Compounds
The present invention provides a compound of a formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof; a process for preparing such a...
2018/0162837 NON-SELECTIVE KINASE INHIBITORS
Disclosed herein are compounds, compositions, and methods for preventing and treating proliferative diseases associated with aberrant receptor tyrosine kinase...
2018/0162836 INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
This present disclosure is directed to compounds of formula (I): ##STR00001## where R.sup.1a, R.sup.3, Y, and Z are described herein, as single stereoisomers...
2018/0162835 QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS
The present disclosure relates to inhibitors of USP7 inhibitors useful in the treatment of cancers, neurodegenerative diseases, immunological disorders,...
2018/0162834 Tricyclic Derivative Compound, Method for Preparing Same, and Pharmaceutical Composition Comprising Same
The present invention relates to novel tricyclic derivative compounds, and more specifically to tricyclic derivative compounds, optical isomers thereof,...
2018/0162833 PROCESS FOR THE PREPARATION OF EFINACONAZOLE
The present invention relates to a process for the preparation of Efinaconazole and salts thereof.
2018/0162832 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS
The present invention relates to certain 2-(2,4,5-substituted-anilino)pyrimidine compounds and pharmaceutically acceptable salts thereof which may be useful in...
2018/0162831 PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the...
2018/0162830 PROCESSES FOR THE PREPARATION OF 2-THIOPHENECARBONYL CHLORIDE
Provided herein are processes for the preparation of 2-thiophenecarbonyl chloride, which is useful, for example, in the preparation of ...
2018/0162829 TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary...
2018/0162828 Methods of Purifying Cannabinoids, Compositions and Kits Thereof
The present specification discloses methods of purifying one or more cannabinoids from a plant material, purified cannabinoids and pharmaceutical compositions...
2018/0162827 RADIOMITIGATING PHARMACEUTICAL FORMULATIONS
The present disclosure relates to compounds of Formula (I) and (II), compositions containing the compounds (alone or in combination with other agents), and...
2018/0162826 PROCESS METHODS FOR PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
A process for the synthesis of quinazolinone containing compounds which may be useful for the treatment of cancer, is hereby disclosed. In addition, compound...
2018/0162825 NOVEL DGAT2 INHIBITORS
The present invention provides compounds of the Formula below: [Formula should be inserted here] Where A, X, R, and R2-R3 are as described herein; methods of...
2018/0162824 PYRIDINE AND PYRIMIDINE DERIVATIVES
The present invention relates to compounds of formula I ##STR00001## wherein R.sup.1' is CH.sub.3 R.sup.1 is methyl, ethyl, CF.sub.3, CH.sub.2OH, cyclopropyl or...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.